Pediatric Infectious Diseases

Study note: This page is for educational purposes. Clinical decisions must follow current guidelines (AAP Red Book, CDC, UpToDate) and institutional protocols.

Learning Objectives

By the end of this page, you should be able to:

• Explain why children's immune systems, anatomy, and pharmacokinetics make them susceptible to a different set of infections than adults.
• Distinguish the major childhood exanthems (measles, rubella, roseola, fifth disease, scarlet fever, varicella, hand-foot-mouth) by rash pattern, prodrome, and causative organism.
• Apply the AAP criteria for immediate antibiotics versus watchful waiting in otitis media.
• Recall the CDC/ACIP immunization schedule and connect specific vaccines to the diseases they prevent.
• Interpret CSF findings to distinguish bacterial from viral meningitis and select empiric antibiotics by age group.
• Identify red flags that separate a benign viral exanthem from a life-threatening pediatric infection.

Quick Answer

Pediatric infectious diseases is the study of infections unique to (or disproportionately affecting) children — driven by an immature immune system, distinctive anatomy (short Eustachian tubes, short urethras), and non-verbal presentation where fever alone may signal serious bacterial infection. It matters because infectious disease remains a leading cause of pediatric morbidity worldwide, and most of it is preventable or treatable: vaccines (CDC/ACIP schedule) prevent the worst outcomes, recognizing rash patterns lets you diagnose exanthems on sight, and knowing when not to give antibiotics (viral URIs, STEC gastroenteritis) is as important as knowing when to give them.

Why Children Are Different

Factor	Implication
Immature immune system (especially neonates/infants)	Higher susceptibility to encapsulated organisms (S. pneumoniae, N. meningitidis, H. influenzae) before vaccination; maternal antibodies wane by 6 months
Developmental anatomy	Short, horizontal Eustachian tubes → more otitis media; short urethras in girls → more UTIs
Drug metabolism	Hepatic enzyme activity differs by age; renal clearance higher in children (higher mg/kg doses of many antibiotics); avoid fluoroquinolones and tetracyclines in young children
Non-verbal presentation	Infants cannot localise pain; fever may be the only sign of serious bacterial infection (SBI) in infants under 3 months
Vaccination status	US immunisation schedule (CDC/ACIP) dramatically changes the differential — vaccinated children have much lower risk of H. influenzae type b, S. pneumoniae bacteraemia, measles, pertussis

Childhood Exanthems

An "exanthem" is a widespread rash accompanying a systemic illness — usually viral in children. Most are diagnosed clinically by matching the rash pattern, prodrome, and age to the classic script below; this is one of the highest-yield pattern-recognition skills in pediatrics.

Disease	Organism	Key distinguishing feature
Roseola infantum	HHV-6	High fever resolves abruptly, then rash appears
Measles (rubeola)	Measles virus (paramyxovirus)	Koplik spots (buccal mucosa) precede rash; 3 C's — cough, coryza, conjunctivitis
Rubella	Rubella virus	Mild illness; posterior auricular/cervical lymphadenopathy; teratogenic in first trimester
Fifth disease	Parvovirus B19	"Slapped cheek" facial rash, then lacy/reticular rash on extremities
Scarlet fever	Streptococcus pyogenes (Group A Strep)	Sandpaper-textured rash, strawberry tongue, circumoral pallor; treat with penicillin to prevent rheumatic fever
Varicella (chickenpox)	Varicella-zoster virus	Pruritic vesicles in different stages of healing simultaneously ("crops")
Hand-foot-mouth disease	Coxsackievirus A16 (enterovirus)	Painful oral ulcers plus vesicles on palms and soles

Why this matters clinically: scarlet fever is the one exanthem here that is bacterial and requires antibiotics (penicillin/amoxicillin) specifically to prevent acute rheumatic fever — every other one on this list is viral and self-limited. Getting this distinction right is a recurring exam trap.

The CDC/ACIP Recommended Immunisation Schedule (US)

Vaccinations are the most effective intervention in pediatric infectious disease. The US CDC and Advisory Committee on Immunization Practices (ACIP) publish the annual schedule:

Vaccine	Diseases prevented	Schedule (key doses)
DTaP	Diphtheria, tetanus, pertussis	2, 4, 6 months; 15–18 months; 4–6 years
IPV	Poliomyelitis	2, 4 months; 6–18 months; 4–6 years
MMR	Measles, mumps, rubella	12–15 months; 4–6 years
Varicella	Chickenpox	12–15 months; 4–6 years
Hib	H. influenzae type b meningitis	2, 4, 6 months; 12–15 months
PCV15/PCV20	S. pneumoniae (pneumococcal)	2, 4, 6 months; 12–15 months
Rotavirus	Rotavirus gastroenteritis	2, 4 months (some formulations add 6 months)
Hepatitis B	HBV infection	Birth; 1–2 months; 6–18 months
Influenza	Seasonal flu	Annually from 6 months; two doses in first season
COVID-19	SARS-CoV-2	Per current ACIP recommendations

Outbreak context: Measles had been declared eliminated from the US in 2000. However, outbreaks continue to occur among unvaccinated communities (e.g., 2019 outbreak in NY with 1,282 cases, largest since 1992). Maintaining >95% MMR coverage is critical for herd immunity — this threshold is why a single unvaccinated cluster can reignite transmission even in a highly vaccinated country.

Common Pediatric Infectious Diseases

1. Respiratory Syncytial Virus (RSV) Bronchiolitis

Epidemiology: RSV is the leading cause of lower respiratory tract infection in infants globally. In the US, RSV accounts for ~58,000–80,000 pediatric hospitalisations/year. Peak season: November–March.

Clinical features:

• Affects infants < 2 years (peak: 2–6 months)
• Upper respiratory symptoms (rhinorrhoea, cough) progress over 3–5 days to lower respiratory tract: wheezing, tachypnoea, retractions, nasal flaring, feeding difficulty

Diagnosis: Clinical; RSV PCR or rapid antigen test confirms

Management (AAP 2014 Guidelines):

• Primarily supportive: hydration, nasal suctioning, supplemental oxygen if SpO₂ < 90%
• Avoid routine bronchodilators (albuterol), steroids, chest physiotherapy — no evidence of benefit
• Hospitalise if: SpO₂ persistently < 90%, moderate-severe respiratory distress, poor feeding, apnoea

Prevention:

• Nirsevimab (Beyfortus): Long-acting monoclonal antibody approved by FDA 2023; recommended by ACIP for all infants < 8 months entering their first RSV season
• RSV maternal vaccine (Abrysvo): FDA-approved 2023 for pregnant women at 32–36 weeks gestational age to protect newborns via passive immunity

2. Bacterial Meningitis

Aetiology varies by age:

Age group	Common organisms
Neonates (0–28 days)	E. coli, Group B Streptococcus (GBS), L. monocytogenes
Infants 1–3 months	GBS, E. coli, S. pneumoniae, N. meningitidis
Children/adolescents	S. pneumoniae, N. meningitidis

Classic presentation: Fever + headache + neck stiffness (Kernig's and Brudzinski's signs) + photophobia. In infants: bulging fontanelle, high-pitched cry, irritability, hypothermia possible.

Diagnosis: Lumbar puncture (LP) — CSF analysis:

• Bacterial: WBC > 1000 (PMN predominant), protein ↑↑, glucose ↓ (CSF:serum ratio < 0.4)
• Viral: WBC 10–500 (lymphocyte predominant), protein mildly ↑, glucose normal

Management:

• Empiric antibiotics immediately — do not delay for LP if patient is haemodynamically unstable
• Neonates: Ampicillin + gentamicin (or cefotaxime)
• Infants/children: Vancomycin + ceftriaxone (covers resistant S. pneumoniae)
• Dexamethasone: Given before or with first antibiotic dose for H. influenzae type b or pneumococcal meningitis — reduces hearing loss complication by ~50%

Complications: Sensorineural hearing loss (most common — hearing screen before discharge), intellectual disability, seizures, hydrocephalus, cerebral infarction

3. Otitis Media (OM)

Most common bacterial infection requiring antibiotics in US children; ~5 million cases/year. Peak age: 6–18 months, because the short, horizontal Eustachian tube in this age group drains poorly and lets nasopharyngeal organisms reflux into the middle ear.

Organisms: S. pneumoniae, H. influenzae (non-typeable), M. catarrhalis

AAP 2013 guidelines:

• Immediate antibiotics: children < 6 months, severe symptoms (fever ≥ 39°C, severe otalgia), bilateral OM in children < 2 years, OM with otorrhoea
• Watchful waiting (24–48 hours): children 2+ years with unilateral non-severe OM — many resolve spontaneously
• First-line: Amoxicillin 80–90 mg/kg/day (high dose due to resistant S. pneumoniae)
• Treatment failure: Amoxicillin-clavulanate

4. Urinary Tract Infections (UTIs)

Epidemiology: Girls > boys after infancy (males, especially uncircumcised, have higher risk in first year of life).

Clinical features by age:

• Neonates/infants: Non-specific — fever, poor feeding, irritability, vomiting
• Older children: Dysuria, frequency, urgency, suprapubic pain, flank pain (pyelonephritis)

Organisms: E. coli (~80%), Klebsiella, Proteus, Enterococcus

Diagnosis: Urine culture + sensitivity (catheter specimen in young children — bag specimens unreliable)

Management:

• Cystitis: Oral TMP-SMX or nitrofurantoin 7–10 days
• Pyelonephritis: IV ceftriaxone initially if unable to tolerate oral; oral step-down when tolerating
• Renal ultrasound after first febrile UTI in young children; VCUG if recurrent or abnormal ultrasound (to exclude vesicoureteral reflux)

5. Gastroenteritis

Most common cause of dehydration in US children. Rotavirus vaccination has dramatically reduced hospitalisation since 2006.

Viral (most common):

• Rotavirus (now less common post-vaccine), Norovirus (most common in US now), Adenovirus
• Management: Oral rehydration therapy (ORT) — WHO/UNICEF ORS solution preferred over juice/sports drinks; zinc supplementation in developing world settings; probiotics (Lactobacillus rhamnosus GG) modestly reduce duration

Bacterial (consider if: bloody diarrhoea, high fever, systemic toxicity, epidemiological exposure):

• Salmonella, Campylobacter, Shiga toxin-producing E. coli (STEC O157:H7)
• Important: Avoid antibiotics in STEC infection — may increase risk of haemolytic uremic syndrome (HUS)

6. Skin and Soft Tissue Infections (SSTIs)

Community-acquired MRSA (CA-MRSA) has dramatically changed SSTI management in the US. USA300 strain predominates in US community settings.

• Impetigo: S. aureus or S. pyogenes — topical mupirocin or retapamulin for localised; oral antibiotics for widespread
• Cellulitis: Usually streptococcal; treat with cephalexin or amoxicillin-clavulanate
• Abscess: I&D (incision and drainage) is primary treatment; oral TMP-SMX or clindamycin for CA-MRSA coverage in high-prevalence areas (most of the US)
• Necrotising fasciitis: Surgical emergency — immediate debridement + broad-spectrum antibiotics (pip-tazo + vancomycin ± clindamycin for toxin suppression)

Antimicrobial Stewardship in Pediatrics

The CDC's antimicrobial stewardship initiative targets unnecessary antibiotic prescribing. Children receive more antibiotics per capita than any other age group in the US. Key principles:

1. Viral infections do not need antibiotics: Most URIs, bronchiolitis, and gastroenteritis are viral
2. Watchful waiting for mild otitis media and mild sinusitis
3. Narrow-spectrum preferred: Use amoxicillin rather than azithromycin for streptococcal pharyngitis; reserve broad-spectrum for proven need
4. Duration matters: Shorter antibiotic courses (5 days vs. 10 days for some OM) are effective and reduce resistance

US Reporting and Public Health

Certain pediatric infectious diseases are nationally notifiable (CDC/CSTE) — physicians must report to state health departments, which report to CDC:

• Measles, mumps, rubella, pertussis (whooping cough)
• Meningococcal disease
• Haemophilus influenzae invasive disease
• Salmonellosis, shigellosis, STEC
• Tuberculosis

The CDC's National Notifiable Diseases Surveillance System (NNDSS) aggregates this data to detect outbreaks and guide public health responses.

Key Terms

Term	Definition
Exanthem	A widespread skin rash accompanying a systemic (usually viral) illness
Koplik spots	Small white/blue-grey spots on the buccal mucosa, pathognomonic for early measles
Herd immunity	Population-level protection that occurs when enough people are immune to interrupt disease transmission (~95% for measles)
Watchful waiting	Deferring antibiotics for 24–48 hours in mild otitis media to allow spontaneous resolution
CSF pleocytosis	Elevated white cell count in cerebrospinal fluid; pattern (PMN vs lymphocyte) distinguishes bacterial from viral meningitis
HUS (haemolytic uremic syndrome)	Triad of haemolytic anaemia, thrombocytopenia, and acute kidney injury; a feared complication of STEC infection, worsened by antibiotics
Nirsevimab	Long-acting monoclonal antibody providing passive immunity against RSV in infants
Nationally notifiable disease	A condition that clinicians must report to public health authorities so CDC can track outbreaks via the NNDSS

Common Mistakes

Misconception 1: "A rash with fever always means the child needs antibiotics." Why it's wrong: Most childhood exanthems (roseola, measles, rubella, fifth disease, varicella, hand-foot-mouth) are viral and self-limited. Correct understanding: Only scarlet fever (Group A Strep) among the classic exanthems needs antibiotics — specifically penicillin, to prevent rheumatic fever. Treating a viral exanthem with antibiotics adds risk without benefit.

Misconception 2: "Every child with a fever and diarrhea should get antibiotics to clear the infection faster." Why it's wrong: In suspected STEC (E. coli O157:H7) infection — bloody diarrhoea after undercooked beef, unpasteurised milk, or petting-zoo exposure — antibiotics increase toxin release and raise the risk of haemolytic uremic syndrome (HUS). Correct understanding: Bloody diarrhoea in a child should prompt stool culture and supportive care first; withhold antibiotics until STEC is excluded or a non-STEC bacterial cause is confirmed.

Misconception 3: "Any child with ear pain and fever needs antibiotics right away." Why it's wrong: The AAP explicitly allows watchful waiting for children ≥ 2 years with mild, unilateral otitis media, since many cases resolve without treatment. Correct understanding: Immediate antibiotics are reserved for infants < 6 months, severe symptoms, bilateral disease in children < 2 years, or otorrhoea. Otherwise, a 24–48 hour observation window with analgesia is guideline-concordant care.

Comparison and Connections

Feature	Bacterial meningitis	Viral (aseptic) meningitis
CSF WBC	> 1000 cells, PMN-predominant	10–500 cells, lymphocyte-predominant
CSF glucose	Low (CSF:serum ratio < 0.4)	Normal
CSF protein	Markedly elevated	Mildly elevated
Treatment urgency	Empiric IV antibiotics immediately	Supportive care
Course	Can be rapidly fatal without treatment	Usually self-limited

Feature	Measles	Roseola	Scarlet fever
Organism	Measles virus	HHV-6	Group A Strep
Rash timing	Appears with high fever	Appears after fever breaks	Appears with fever, sandpaper texture
Pathognomonic sign	Koplik spots	High fever then abrupt defervescence	Strawberry tongue
Treatment	Supportive (vaccine-preventable)	Supportive	Penicillin (prevents rheumatic fever)

Practice Questions

Recall 1: Name three vaccines given at the 2-month well-child visit and the diseases they prevent. Answer guidance: DTaP (diphtheria, tetanus, pertussis), IPV (polio), Hib (H. influenzae type b meningitis), PCV (pneumococcal disease), rotavirus vaccine — any three with correct disease pairing.

Recall 2: What organism causes scarlet fever, and what is the classic rash texture? Answer guidance: Streptococcus pyogenes (Group A Strep); sandpaper-textured rash, often with strawberry tongue and circumoral pallor.

Understanding 1: Explain why infants under 3 months with fever are managed more aggressively than older children with the same temperature. Answer guidance: Their immune systems are immature, maternal antibody protection is waning, and they cannot localise symptoms — fever may be the only clue to a serious bacterial infection (meningitis, bacteraemia, UTI), so the threshold for full sepsis workup and empiric antibiotics is much lower.

Understanding 2: Why does the AAP recommend giving dexamethasone before or with the first antibiotic dose in suspected H. influenzae or pneumococcal meningitis? Answer guidance: Antibiotic-induced bacterial lysis releases inflammatory cell wall products that worsen CNS inflammation; dexamethasone blunts this inflammatory response and reduces the incidence of sensorineural hearing loss by roughly half.

Application 1: A 4-year-old has a low-grade fever and mild unilateral ear pain for one day, with a normal-appearing tympanic membrane exam otherwise. What is the appropriate initial management per AAP guidelines? Answer guidance: Watchful waiting for 24–48 hours with analgesia, since the child is over 2 years old with mild, unilateral symptoms; prescribe antibiotics only if symptoms worsen or fail to improve.

Application 2: A toddler develops bloody diarrhoea three days after a family barbecue with undercooked ground beef. The parents ask for antibiotics. What do you advise, and why? Answer guidance: Hold antibiotics and send a stool culture for STEC (E. coli O157:H7); antibiotics can increase toxin release and precipitate haemolytic uremic syndrome. Manage with supportive hydration and monitor renal function and haemoglobin closely.

Analysis 1: Compare the CSF profile you would expect in a 6-year-old with bacterial meningitis versus one with enteroviral (viral) meningitis, and explain how each finding follows from the underlying pathophysiology. Answer guidance: Bacterial meningitis produces a robust neutrophilic response (PMN-predominant WBC > 1000), consumption of CSF glucose by bacteria and inflammatory cells (low glucose, ratio < 0.4), and blood-brain barrier breakdown raising protein sharply. Viral meningitis triggers a milder lymphocytic response (WBC 10–500), organisms don't consume glucose the same way (normal glucose), and barrier disruption is less severe (mildly elevated protein).

Analysis 2: A child presents with a rash. Walk through how you would distinguish measles from rubella from fifth disease using only history and rash pattern. Answer guidance: Measles has a significant prodrome (high fever, cough, coryza, conjunctivitis) with Koplik spots preceding a cephalocaudal-spreading rash. Rubella is much milder, with a pink rash and prominent posterior cervical/auricular lymphadenopathy, and matters most for its teratogenic risk in pregnancy. Fifth disease starts with a "slapped cheek" facial rash and mild/absent prodrome, followed by a lacy, reticular rash on the extremities.

FAQ

Q: Why do children get more ear infections than adults? A: Their Eustachian tubes are shorter, more horizontal, and less able to drain, so bacteria from the nasopharynx reflux into the middle ear more easily. As the tube lengthens and angles more steeply with growth, otitis media becomes much less common after age 6–7.

Q: If most exanthems are viral, why does it matter which one a child has? A: Correct identification changes management (scarlet fever needs penicillin), triggers public health reporting (measles, rubella), and matters for pregnancy exposure counselling (rubella and fifth disease are both concerning in pregnant contacts).

Q: Why is fever in a 2-month-old treated so differently than fever in a 5-year-old? A: Young infants can't mount or localise symptoms reliably, have immature immune systems, and are at real risk of serious bacterial infection presenting with fever alone — so most institutions mandate a full sepsis workup and empiric antibiotics below a certain age threshold, unlike an older, vaccinated, verbal child.

Q: Does the MMR vaccine cause autism? A: No. This claim originated from a 1998 study that was retracted for data fabrication and researcher misconduct; multiple large epidemiological studies since have found no link between MMR and autism.

Q: Why is amoxicillin dosed so much higher in children with otitis media than a typical adult antibiotic dose? A: The high dose (80–90 mg/kg/day) is specifically chosen to overcome intermediate-resistance S. pneumoniae strains by achieving higher middle-ear drug concentrations, not because children generally need more drug per kg than adults.

Quick Revision

• Children ≠ small adults: immature immunity, unique anatomy, non-verbal presentation, different pharmacokinetics.
• Exanthem rash-timing trick: rash after fever breaks = roseola; rash with high fever = measles.
• Scarlet fever (Group A Strep) is the only classic exanthem that is bacterial and needs antibiotics (penicillin) — to prevent rheumatic fever.
• Koplik spots = pathognomonic for measles, appear before the rash.
• Bacterial meningitis CSF: WBC > 1000, PMN-predominant, low glucose, high protein. Viral: lower WBC, lymphocyte-predominant, normal glucose.
• Dexamethasone given with/before first antibiotic dose in H. flu/pneumococcal meningitis halves risk of hearing loss.
• Otitis media: immediate antibiotics if < 6 months, severe symptoms, bilateral in < 2 years, or otorrhoea; watchful waiting otherwise.
• Amoxicillin 80–90 mg/kg/day is first-line for OM due to resistant S. pneumoniae.
• Never give antibiotics for suspected STEC gastroenteritis — risk of HUS.
• CDC/ACIP schedule: DTaP, IPV, MMR, Varicella, Hib, PCV, Rotavirus, HepB, Influenza, COVID-19 — know the diseases each prevents.

• 95% MMR coverage needed to sustain herd immunity against measles.

• Nirsevimab gives passive RSV immunity to infants < 8 months entering their first RSV season.

Related Topics

Prerequisites: General pediatric growth and development milestones; basic microbiology of common bacterial and viral pathogens; principles of the immune system (innate vs adaptive immunity).

Related Topics: Neonatal sepsis and Group B Streptococcus prophylaxis; pediatric fever without a source algorithms; antimicrobial pharmacokinetics and weight-based dosing in children.

Next Topics: Meningococcal vaccines (MenACWY, MenB) and their specific indications; pediatric tuberculosis screening and management; congenital and perinatal infections (TORCH).